Atlas Trials

Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients

Clinical trial NCT04720326 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04720326
Sponsor
Edward Geissler
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Prophylaxis Against Liver Transplant Rejection
Start date
2020-12-23
Primary completion
2024-01-25
Enrollment
268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.